Reply
Christophe Bureau, Jean Pierre Vinel, Olivier Lairez – 12 December 2019
Christophe Bureau, Jean Pierre Vinel, Olivier Lairez – 12 December 2019
Zhixiang Hu, Liangqing Dong, Shengli Li, Zhe Li, Yejun Qiao, Yuchen Li, Jie Ding, Zhiao Chen, Yangjun Wu, Zhen Wang, Shenglin Huang, Qiang Gao, Yingjun Zhao, Xianghuo He – 9 December 2019
Marc G. Ghany, Timothy R. Morgan, AASLD‐IDSA Hepatitis C Guidance Panel – 9 December 2019
Marc G. Ghany, Timothy R. Morgan, AASLD‐IDSA Hepatitis C Guidance Panel – 9 December 2019
Kedar Patil, Amanda Ricciuto, Alaa Alsharief, Jehan Al‐Rayahi, Afsaneh Amirabadi, Peter C. Church, Binita M. Kamath, Mary‐Louise C. Greer – 6 December 2019 – Magnetic resonance cholangiopancreatography (MRCP) has not been assessed as a surrogate biomarker in pediatrics. We aimed to determine the inter‐rater reliability, prognostic utility, and construct validity of the modified Majoie endoscopic retrograde cholangiopancreatography classification applied to MRCP in a pediatric primary sclerosing cholangitis (PSC) cohort.
Guido Carpino, Maria Del Ben, Daniele Pastori, Roberto Carnevale, Francesco Baratta, Diletta Overi, Heather Francis, Vincenzo Cardinale, Paolo Onori, Samira Safarikia, Vittoria Cammisotto, Domenico Alvaro, Gianluca Svegliati‐Baroni, Francesco Angelico, Eugenio Gaudio, Francesco Violi – 6 December 2019
Zhipeng Li, Shaun G. Weller, Kristina Drizyte‐Miller, Jing Chen, Eugene W. Krueger, Bridget Mehall, Jacqueline Stöckli, Carol A. Casey, Hong Cao, Mark A. McNiven – 6 December 2019
Mohamed I. Elsaid, You Li, Tina John, Navaneeth Narayanan, Carolyn Catalano, Vinod K. Rustgi – 5 December 2019
Jessica L. Petrick, Andrea A. Florio, Xuehong Zhang, Anne Zeleniuch‐Jacquotte, Jean Wactawski‐Wende, Stephen K. Van Den Eeden, Frank Z. Stanczyk, Tracey G. Simon, Rashmi Sinha, Howard D. Sesso, Catherine Schairer, Lynn Rosenberg, Thomas E. Rohan, Mark P. Purdue, Julie R. Palmer, Martha S. Linet, Linda M. Liao, I‐Min Lee, Jill Koshiol, Cari M. Kitahara, Victoria A. Kirsh, Jonathan N. Hofmann, Chantal Guillemette, Barry I. Graubard, Edward Giovannucci, J. Michael Gaziano, Susan M. Gapster, Neal D. Freedman, Lawrence S. Engel, Dawn Q. Chong, Yu Chen, Andrew T. Chan, Patrick Caron, Julie E.
Suk Kyun Hong, Kyung‐Suk Suh, Kyung Ae Kim, Jeong‐Moo Lee, Jae‐Hyung Cho, Nam‐Joon Yi, Kwang‐Woong Lee – 5 December 2019 – Pure laparoscopic donor hepatectomy (PLDH) has become increasingly accepted in the era of minimally invasive surgeries. However, the outcomes of pure laparoscopic donor left hepatectomy (PLDLH) are relatively less known than for left lateral sectionectomy or right hepatectomy. This study aimed to report our experience with and the outcomes of PLDLH including the middle hepatic vein (MHV) and to compare these outcomes with conventional donor left hepatectomy (CDLH).